Position in LNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,424,482
New position
Shares Held
21,854
first reported quarter
Ownership
0.033%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#146
of 466 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAXTON ASSOCIATES LLP holds $23,868,011 across 6 Drug Manufacturers - Specialty & Generic names. LNTH ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
112,856 | $8,109,832 | |
| 2 | LQDA |
Liquidia Corp
|
92,656 | $7,387,462 | |
| 3 | VTRS |
Viatris Inc
|
255,423 | $4,056,117 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
This page
|
21,854 | $2,424,482 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
56,917 | $1,443,984 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
9,438 | $446,134 |
All Filings in LNTH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,424,482 | 21,854 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||